miR-19a-3p containing exosomes improve function of ischaemic myocardium upon shock wave therapy.


Journal

Cardiovascular research
ISSN: 1755-3245
Titre abrégé: Cardiovasc Res
Pays: England
ID NLM: 0077427

Informations de publication

Date de publication:
01 05 2020
Historique:
received: 22 11 2018
revised: 28 06 2019
accepted: 12 08 2009
pubmed: 15 8 2019
medline: 9 2 2021
entrez: 15 8 2019
Statut: ppublish

Résumé

As many current approaches for heart regeneration exert unfavourable side effects, the induction of endogenous repair mechanisms in ischaemic heart disease is of particular interest. Recently, exosomes carrying angiogenic miRNAs have been described to improve heart function. However, it remains challenging to stimulate specific release of reparative exosomes in ischaemic myocardium. In the present study, we sought to test the hypothesis that the physical stimulus of shock wave therapy (SWT) causes the release of exosomes. We aimed to substantiate the pro-angiogenic impact of the released factors, to identify the nature of their cargo, and to test their efficacy in vivo supporting regeneration and recovery after myocardial ischaemia. Mechanical stimulation of ischaemic muscle via SWT caused extracellular vesicle (EV) release from endothelial cells both in vitro and in vivo. Characterization of EVs via electron microscopy, nanoparticle tracking analysis and flow cytometry revealed specific exosome morphology and size with the presence of exosome markers CD9, CD81, and CD63. Exosomes exhibited angiogenic properties activating protein kinase b (Akt) and extracellular-signal regulated kinase (ERK) resulting in enhanced endothelial tube formation and proliferation. A miRNA array and transcriptome analysis via next-generation sequencing were performed to specify exosome content. miR-19a-3p was identified as responsible cargo, antimir-19a-3p antagonized angiogenic exosome effects. Exosomes and target miRNA were injected intramyocardially in mice after left anterior descending artery ligation. Exosomes resulted in improved vascularization, decreased myocardial fibrosis, and increased left ventricular ejection fraction as shown by transthoracic echocardiography. The mechanical stimulus of SWT causes release of angiogenic exosomes. miR-19a-3p is the vesicular cargo responsible for the observed effects. Released exosomes induce angiogenesis, decrease myocardial fibrosis, and improve left ventricular function after myocardial ischaemia. Exosome release via SWT could develop an innovative approach for the regeneration of ischaemic myocardium.

Identifiants

pubmed: 31410448
pii: 5549496
doi: 10.1093/cvr/cvz209
doi:

Substances chimiques

MIRN19 microRNA, human 0
MIRN19 microRNA, mouse 0
MicroRNAs 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1226-1236

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Auteurs

Can Gollmann-Tepeköylü (C)

Department of Cardiac Surgery, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.
Austrian Cluster for Tissue Regeneration, Vienna, Austria.

Leo Pölzl (L)

Department of Cardiac Surgery, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.
Austrian Cluster for Tissue Regeneration, Vienna, Austria.

Michael Graber (M)

Department of Cardiac Surgery, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.
Division of Clinical and Functional Anatomy, Medical University of Innsbruck, Innsbruck, Austria.

Jakob Hirsch (J)

Department of Cardiac Surgery, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.
Austrian Cluster for Tissue Regeneration, Vienna, Austria.

Felix Nägele (F)

Department of Cardiac Surgery, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.
Austrian Cluster for Tissue Regeneration, Vienna, Austria.

Daniela Lobenwein (D)

Department of Cardiac Surgery, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.
Division of Clinical and Functional Anatomy, Medical University of Innsbruck, Innsbruck, Austria.

Michael W Hess (MW)

Division of Histology and Embryology, Medical University of Innsbruck, Innsbruck, Austria.

Michael J Blumer (MJ)

Division of Clinical and Functional Anatomy, Medical University of Innsbruck, Innsbruck, Austria.

Elke Kirchmair (E)

Department of Cardiac Surgery, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.
Austrian Cluster for Tissue Regeneration, Vienna, Austria.

Johannes Zipperle (J)

Austrian Cluster for Tissue Regeneration, Vienna, Austria.
Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, AUVA Trauma Research Center, Vienna, Austria.

Carina Hromada (C)

Austrian Cluster for Tissue Regeneration, Vienna, Austria.
Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, AUVA Trauma Research Center, Vienna, Austria.

Severin Mühleder (S)

Austrian Cluster for Tissue Regeneration, Vienna, Austria.
Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, AUVA Trauma Research Center, Vienna, Austria.

Hubert Hackl (H)

Division of Bioinformatics, Medical University of Innsbruck, Innsbruck, Austria.

Martin Hermann (M)

Department of Anesthesiology, Medical University of Innsbruck, Innsbruck, Austria.

Hemse Al Khamisi (H)

Laboratory of Experimental Cardiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Martin Förster (M)

Department of Cardiology, Pneumology and Angiology, Friedrich-Schiller-University Jena, Jena, Germany.

Michael Lichtenauer (M)

Department of Cardiology, Paracelsus Medical University Salzburg, Salzburg, Austria.

Rainer Mittermayr (R)

Austrian Cluster for Tissue Regeneration, Vienna, Austria.
AUVA Trauma Center Meidling, Vienna, Austria.

Patrick Paulus (P)

Department of Anesthesiology and Operative Intensive Care Medicine, Kepler University Hospital Linz, Linz, Austria.

Helga Fritsch (H)

Division of Histology and Embryology, Medical University of Innsbruck, Innsbruck, Austria.

Nikolaos Bonaros (N)

Department of Cardiac Surgery, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.

Rudolf Kirchmair (R)

Department of Internal Medicine III, Medical University of Innsbruck, Innsbruck, Austria.

Joost P G Sluijter (JPG)

Laboratory of Experimental Cardiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Sean Davidson (S)

Hatter Cardiovascular Institute, University College London, London, UK.

Michael Grimm (M)

Department of Cardiac Surgery, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.

Johannes Holfeld (J)

Department of Cardiac Surgery, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.
Austrian Cluster for Tissue Regeneration, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH